How to Deal with Constipation from Ozempic: Effective Strategies for Relief

Last reviewed: June 27, 2026

Last updated: June 27, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide slows stomach emptying to reduce appetite, but this mechanism can trigger constipation in roughly one-quarter of users within the first four weeks of treatment. Understanding why this happens and how to address it helps you stay on your medication without discomfort. PlexusDx provides personalized guidance to help patients navigate GLP-1 therapy successfully.

Why Semaglutide Causes Constipation

Semaglutide works by activating GLP-1 receptors in the gut, which delays how fast food moves through your stomach and intestines. This intentional slowdown reduces hunger signals to your brain, making you feel satisfied on smaller meals. However, slower gastric transit time can reduce bowel movement frequency and make stool harder to pass.

Your gut microbiome also shifts when you consume fewer calories and less fiber. Beneficial bacteria that support regular bowel movements may decrease, further contributing to constipation. Additionally, dehydration is common during weight loss, and inadequate fluid intake worsens stool hardness. These factors often combine to create the constipation that many semaglutide users report.

Hydration and Fiber: The Foundation of Relief

Increasing water intake to 80–100 ounces daily is the first and most impactful step. Proper hydration softens stool and helps your colon move waste more efficiently, offsetting the slowing effect of semaglutide. Many patients see improvement within 2–3 days of deliberately drinking more water throughout the day.

Gradually raising fiber intake (aim for 25–35 grams daily) supports healthy bowel flora and bulk. Start with whole grains, leafy greens, berries, and legumes rather than supplements, which can sometimes worsen bloating. Add fiber slowly over one to two weeks so your digestive system adapts without gas or cramping. The combination of extra water plus gradual fiber increase resolves constipation in most patients without medication.

Movement, Magnesium, and Over-the-Counter Options

Light physical activity—such as a 15-minute walk after meals—stimulates intestinal muscles and promotes natural bowel movement. Even gentle daily movement can reduce constipation severity by 30–40% according to gastroenterology studies. Combining exercise with hydration creates a powerful, medication-free approach.

Magnesium glycinate (200–400 mg daily) relaxes smooth muscle in the colon and draws water into stool, making bowel movements easier. Unlike harsh laxatives, magnesium is gentle and supports overall health. Osmotic agents like polyethylene glycol (Miralax) are also safe for long-term use and work by increasing water retention in the intestinal tract. Consult your PlexusDx provider before adding any supplement to ensure it complements your semaglutide therapy.

When to Adjust Dosing or Seek Medical Guidance

Constipation that persists beyond two weeks despite hydration, fiber, and activity warrants a conversation with your prescriber. Some patients benefit from slowing their semaglutide dose escalation, allowing the gut more time to adapt. Others find relief by spacing doses differently or temporarily holding at a lower dose before advancing.

PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan and are provided with flexible dosing schedules tailored to your tolerance. Your dose may need to go up, but your price won't—allowing your healthcare team to find the right balance between appetite suppression and digestive comfort. If constipation is severe or accompanied by abdominal pain, nausea, or vomiting, contact your provider immediately to rule out other conditions.

Personalized Approaches: Genetic Insights and Individual Response

The PlexusDx Precision Peptide Genetic Test ($298) analyzes MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Patients with certain genetic profiles may be more prone to constipation and benefit from earlier fiber supplementation or dose adjustments. Others tolerate rapid dose escalation without digestive disruption. Understanding your peptide pathways empowers you and your PlexusDx team to personalize your treatment plan, reducing side effect burden while maximizing weight loss results. Available in all 50 states without insurance, PlexusDx therapy is HSA/FSA eligible for added affordability.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

How long does semaglutide constipation usually last?

Most patients experience peak constipation during the first 2–4 weeks on semaglutide, with improvement by week 6–8 as the body adapts. Implementing hydration, fiber, and movement strategies within the first week significantly shortens symptom duration. If constipation persists beyond two weeks despite lifestyle changes, contact your PlexusDx provider about dose timing or escalation adjustments.

Is constipation a sign that semaglutide is working?

Constipation is a common side effect but not a requirement for weight loss success. The appetite-suppressing effect of semaglutide and constipation stem from the same mechanism—slowed gastric emptying—but many patients achieve excellent results with minimal digestive disruption. Addressing constipation early does not reduce the medication's effectiveness.

Can I use laxatives regularly while taking semaglutide?

Stimulant laxatives (like senna or bisacodyl) can be used occasionally, but long-term reliance may reduce effectiveness and cause dependency. Osmotic laxatives (polyethylene glycol) are gentler for ongoing use. Discuss any laxative with your prescriber before starting, as some interactions with GLP-1 therapy are possible. PlexusDx providers can recommend appropriate options during your first consultation.

What is the PlexusDx Precision Peptide Genetic Test?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Does compounded semaglutide from PlexusDx cause more constipation than brand-name Ozempic?

PlexusDx compounded semaglutide is manufactured by licensed 503A compounding pharmacies and contains the same active compound as Ozempic, so constipation rates are equivalent. The benefit of PlexusDx is flexible, personalized dosing—your price stays flat at $189/mo starting, so your team can adjust your dose without worrying about cost barriers to finding your optimal comfort level.

Related Reading

• Glp1 Constipation Relief Plexusdx
• What Are The Genetic Factors In Constipation And Effective Management
• What Are The Genetic Factors In Nerve Compression Disorders And Effective Management Strategies
• Key Features Of Emotional Blindness And Effective Management Strategies

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.